Application 207534
- Type
- NDA
- Sponsor
- ADAMIS PHARMS CORP
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SYMJEPI | EPINEPHRINE | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 0.3MG/0.3ML (0.3MG/0.3ML) | Yes | Yes |
| 002 | SYMJEPI | EPINEPHRINE | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 0.15MG/0.3ML (0.15MG/0.3ML) | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N207534-001 | SYMJEPI | EPINEPHRINE | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | |
| N207534-002 | SYMJEPI | EPINEPHRINE | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 |
| N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2018-09-27 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2018-09-27 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2018-09-27 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2018-09-27 | 74a2ff9319b5… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 8072bd15b7f6… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 6a51e52b5d6a… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 1c564ffb4f44… |
| 2024-02-18 07:12 UTC | 2024-02 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | a72a2bbeb626… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Epinephrine | EPINEPHRINE | Medical Purchasing Solutions, LLC | 093312af-6eed-1f4b-e063-6294a90a155d | 2023-11-02 | Warnings, Adverse reactions | EPINEPHRINE |
| epinephrine | EPINEPHRINE | American Regent, Inc. | 6add7604-71f6-4d8a-9447-17ad01fa839d | 2023-10-01 | Warnings, Adverse reactions | EPINEPHRINE |
| EPIPEN | EPINEPHRINE | Asclemed USA, Inc. | 311af6d9-20c0-4b87-b236-4185bfa49988 | 2023-08-29 | Warnings, Adverse reactions | EPINEPHRINE |
| Adrenalinum | EPINEPHRINE | Boiron | 84b2e61b-7c92-5a2e-e053-2a91aa0a626c | 2023-07-12 | EPINEPHRINE | |
| Epinephrine | EPINEPHRINE | Medical Purchasing Solutions, LLC | 6bce7d5c-bb6b-1f36-e053-2a91aa0a68ab | 2023-05-22 | Warnings, Adverse reactions | EPINEPHRINE |
| Epinephrine | EPINEPHRINE | Medical Purchasing Solutions, LLC | 6bdca08a-65bf-f56c-e053-2a91aa0a56d8 | 2023-05-22 | Warnings, Adverse reactions | EPINEPHRINE |
| Adrenalin | EPINEPHRINE | Medical Purchasing Solutions, LLC | b622a9b9-2f09-46e4-e053-2995a90aae01 | 2023-05-04 | Warnings, Adverse reactions | EPINEPHRINE |
| EPINEPHRINE | EPINEPHRINE | Medical Purchasing Solutions, LLC | c4327095-3a89-d86a-e053-2a95a90ac255 | 2023-04-27 | Warnings, Adverse reactions | EPINEPHRINE |
| Auvi-Q | EPINEPHRINE | Medical Purchasing Solutions, LLC | 8f110633-bf37-458d-e053-2a95a90a8fa9 | 2023-04-26 | Warnings, Adverse reactions | EPINEPHRINE |
| Auvi-Q | EPINEPHRINE | Medical Purchasing Solutions, LLC | 8f00231e-be88-49fe-e053-2a95a90ab6dd | 2023-04-26 | Warnings, Adverse reactions | EPINEPHRINE |
| Epinephrine | EPINEPHRINE | American Regent, Inc. | 61cacda5-64ee-45ca-b94c-e8640c43e581 | 2023-04-01 | Warnings, Adverse reactions | EPINEPHRINE |
| EPIPEN | EPINEPHRINE | Viatris Specialty LLC | 7560c201-9246-487c-a13b-6295db04274a | 2023-02-15 | Warnings, Adverse reactions | EPINEPHRINE |
| Epinephrine | EPINEPHRINE | Viatris Specialty LLC | 778ac6ae-6bcb-47a4-bcb3-8dd0da9f8836 | 2023-02-15 | Warnings, Adverse reactions | EPINEPHRINE |
| EPINEPHRINE | EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | 75dbc3f5-9caf-9f55-e053-2a91aa0a4719 | 2022-12-09 | Warnings, Adverse reactions | EPINEPHRINE |
| EPINEPHRINE | EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | 75e96faa-545b-52d6-e053-2991aa0a8fb8 | 2022-12-09 | Warnings, Adverse reactions | EPINEPHRINE |
| Epinephrine | EPINEPHRINE | Medical Purchasing Solutions, LLC | 677c33a2-4e16-406e-e053-2991aa0a4594 | 2022-10-13 | Warnings, Adverse reactions | EPINEPHRINE |
| Epinephrine | EPINEPHRINE | Asclemed USA, Inc. | 099bc72c-8ffe-4b8c-9608-044c864982fb | 2022-10-12 | Warnings, Adverse reactions | EPINEPHRINE |
| Epinephrine | EPINEPHRINE | Teva Pharmaceuticals USA, Inc. | 04f07f15-55e2-411b-abb8-07eab37f5664 | 2021-01-31 | Warnings, Adverse reactions | EPINEPHRINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0781-3442 | SYMJEPI | Epinephrine | Sandoz Inc. | NDA | Current |
| 0781-3442 | SYMJEPI | Epinephrine | Sandoz Inc. | NDA | Current |
| 0781-3442 | SYMJEPI | Epinephrine | Sandoz Inc. | NDA | Current |
| 0781-3442 | SYMJEPI | Epinephrine | Sandoz Inc. | NDA | Current |
| 0781-3442 | SYMJEPI | Epinephrine | Sandoz Inc. | NDA | Current |
| 0781-3448 | SYMJEPI | Epinephrine | Sandoz Inc. | NDA | Current |
| 0781-3448 | SYMJEPI | Epinephrine | Sandoz Inc. | NDA | Current |
| 0781-3448 | SYMJEPI | Epinephrine | Sandoz Inc. | NDA | Current |
| 0781-3448 | SYMJEPI | Epinephrine | Sandoz Inc. | NDA | Current |
| 38739-200 | SYMJEPI | Epinephrine | Adamis Pharmaceuticals Corporation | NDA | Current |
| 78670-130 | Symjepi | epinephrine | USWM, LLC | NDA | Current |
| 78670-130 | Symjepi | epinephrine | USWM, LLC | NDA | Current |
| 78670-130 | Symjepi | epinephrine | USWM, LLC | NDA | Current |
| 78670-130 | Symjepi | epinephrine | USWM, LLC | NDA | Current |
| 78670-131 | Symjepi | epinephrine | USWM, LLC | NDA | Current |
| 78670-131 | Symjepi | epinephrine | USWM, LLC | NDA | Current |
| 78670-131 | Symjepi | epinephrine | USWM, LLC | NDA | Current |
| 78670-131 | Symjepi | epinephrine | USWM, LLC | NDA | Current |